ACLX vs SHW · rev $107.9M vs P/E 29, rev $12.46B
Arcellx Inc (ACLX) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
ACLX currently screens at market cap $6.73B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the ACLX and SHW stock pages for the full models.
Not investment advice.